Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer

Vanaja, 2003, Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression, Cancer Res, 63, 3877

Tomlins, 2005, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, 310, 644, 10.1126/science.1117679

Mosquera, 2009, Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States, Clin Cancer Res, 15, 4706, 10.1158/1078-0432.CCR-08-2927

Tomlins, 2009, ETS gene fusions in prostate cancer: from discovery to daily clinical practice, Eur Urol, 56, 275, 10.1016/j.eururo.2009.04.036

Kumar-Sinha, 2008, Recurrent gene fusions in prostate cancer, Nat Rev Cancer, 8, 497, 10.1038/nrc2402

Han, 2008, A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer, Cancer Res, 68, 7629, 10.1158/0008-5472.CAN-08-2014

Esgueva, 2010, Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort, Mod Pathol, 23, 539, 10.1038/modpathol.2009.193

Pflueger, 2009, N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer, Neoplasia, 11, 804, 10.1593/neo.09572

Carver, 2009, Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate, Nat Genet, 41, 619, 10.1038/ng.370

Han, 2009, Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression, Mod Pathol, 22, 1083, 10.1038/modpathol.2009.69

Perner, 2007, TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion, Am J Surg Pathol, 31, 882, 10.1097/01.pas.0000213424.38503.aa

Mehra, 2007, Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer, Mod Pathol, 20, 538, 10.1038/modpathol.3800769

Perner, 2006, TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer, Cancer Res, 66, 8337, 10.1158/0008-5472.CAN-06-1482

Tomlins, 2008, Role of the TMPRSS2-ERG gene fusion in prostate cancer, Neoplasia, 10, 177, 10.1593/neo.07822

Yu, 2007, Integrative genomics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer, Cancer Cell, 12, 419, 10.1016/j.ccr.2007.10.016

Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310

Mehra, 2007, Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases, Cancer Res, 67, 7991, 10.1158/0008-5472.CAN-07-2043

Barry, 2007, TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications, Urology, 70, 630, 10.1016/j.urology.2007.08.032

Mosquera, 2008, Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications, Clin Cancer Res, 14, 3380, 10.1158/1078-0432.CCR-07-5194

Sato, 2001, Role of ETS family transcription factors in vascular development and angiogenesis, Cell Struct Funct, 26, 19, 10.1247/csf.26.19

Vlaeminck-Guillem, 2000, The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis, Mech Dev, 91, 331, 10.1016/S0925-4773(99)00272-5

Gavrilov, 2001, Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers, Eur J Cancer, 37, 1033, 10.1016/S0959-8049(01)00077-6

Attard, 2009, Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer, Cancer Res, 69, 2912, 10.1158/0008-5472.CAN-08-3667

Hermans, 2006, TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer, Cancer Res, 66, 10658, 10.1158/0008-5472.CAN-06-1871

Mertz, 2007, Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model, Neoplasia, 9, 200, 10.1593/neo.07103

Petrovics, 2005, Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome, Oncogene, 24, 3847, 10.1038/sj.onc.1208518